Skip to Content

Moxifloxacin Injection

Last Updated: January 10, 2018
Status: Resolved

Moxifloxacin Injection

Products Affected - Description
  • Avelox I.V. injection, Bayer
    400 mg/250 mL, premixed bag, 12 count (NDC 50419-0537-01)

    Moxifloxacin injection, Fresenius Kabi
    400 mg/250 mL, premixed bag, 12 count (NDC 63323-0850-74)

Reason for the Shortage
    • Bayer did not provide a reason for the shortage.
    • Fresenius Kabi has moxifloxacin injection on shortage due to increased demand.
Available Products
  • Moxifloxacin injection, Mylan Institutional
    400 mg/250 mL, premixed bag, 12 count (NDC 67457-0323-25)

Estimated Resupply Dates

    • Fresenius Kabi has moxifloxacin 400 mg/250 mL premixed bags on back order and the company estimates a release date of mid- to late-March 2018.
    • Bayer has Avelox I.V. 400 mg/250 mL premixed bags on back order and the company cannot estimate a release date.

Updated

January 10, 2018; December 1, October 30, 2017, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide